Sionna Therapeutics (SION) Competitors $19.14 -0.63 (-3.19%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock SION vs. IMVT, CRNX, KYMR, HCM, MOR, RARE, ARWR, ALVO, MIRM, and CPRXShould you be buying Sionna Therapeutics stock or one of its competitors? The main competitors of Sionna Therapeutics include Immunovant (IMVT), Crinetics Pharmaceuticals (CRNX), Kymera Therapeutics (KYMR), HUTCHMED (HCM), MorphoSys (MOR), Ultragenyx Pharmaceutical (RARE), Arrowhead Pharmaceuticals (ARWR), Alvotech (ALVO), Mirum Pharmaceuticals (MIRM), and Catalyst Pharmaceuticals (CPRX). These companies are all part of the "pharmaceutical products" industry. Sionna Therapeutics vs. Its Competitors Immunovant Crinetics Pharmaceuticals Kymera Therapeutics HUTCHMED MorphoSys Ultragenyx Pharmaceutical Arrowhead Pharmaceuticals Alvotech Mirum Pharmaceuticals Catalyst Pharmaceuticals Immunovant (NASDAQ:IMVT) and Sionna Therapeutics (NASDAQ:SION) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, media sentiment, earnings, dividends and risk. Do insiders and institutionals believe in IMVT or SION? 47.1% of Immunovant shares are owned by institutional investors. 1.8% of Immunovant shares are owned by company insiders. Comparatively, 3.9% of Sionna Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is IMVT or SION more profitable? Sionna Therapeutics' return on equity of 0.00% beat Immunovant's return on equity.Company Net Margins Return on Equity Return on Assets ImmunovantN/A -80.60% -71.89% Sionna Therapeutics N/A N/A N/A Does the media refer more to IMVT or SION? In the previous week, Sionna Therapeutics had 1 more articles in the media than Immunovant. MarketBeat recorded 1 mentions for Sionna Therapeutics and 0 mentions for Immunovant. Sionna Therapeutics' average media sentiment score of 1.79 beat Immunovant's score of 0.00 indicating that Sionna Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment Immunovant Neutral Sionna Therapeutics Very Positive Do analysts rate IMVT or SION? Immunovant currently has a consensus price target of $36.30, indicating a potential upside of 98.14%. Sionna Therapeutics has a consensus price target of $38.50, indicating a potential upside of 101.15%. Given Sionna Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Sionna Therapeutics is more favorable than Immunovant.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Immunovant 0 Sell rating(s) 3 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.82Sionna Therapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable valuation and earnings, IMVT or SION? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioImmunovantN/AN/A-$413.84M-$2.74-6.69Sionna TherapeuticsN/AN/A-$61.69MN/AN/A SummarySionna Therapeutics beats Immunovant on 8 of the 11 factors compared between the two stocks. Get Sionna Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SION and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SION and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SION vs. The Competition Export to ExcelMetricSionna TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$844.46M$3.05B$5.67B$9.49BDividend YieldN/A2.44%4.05%4.00%P/E RatioN/A20.8627.9419.96Price / SalesN/A246.07396.5882.69Price / CashN/A41.9636.1958.45Price / BookN/A8.308.635.82Net Income-$61.69M-$55.19M$3.24B$258.42M7 Day Performance4.42%5.06%3.22%1.94%1 Month Performance19.33%17.59%10.71%12.02%1 Year PerformanceN/A7.02%34.94%20.81% Sionna Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SIONSionna TherapeuticsN/A$19.14-3.2%$38.50+101.1%N/A$844.46MN/A0.0035IMVTImmunovant1.0913 of 5 stars$18.17+2.0%$36.30+99.8%-34.3%$3.11BN/A-6.63120Positive NewsCRNXCrinetics Pharmaceuticals3.6026 of 5 stars$33.01+3.5%$69.50+110.5%-43.5%$3.09B$1.04M-8.64210KYMRKymera Therapeutics3.1557 of 5 stars$46.72+2.7%$59.11+26.5%+6.8%$3.04B$47.07M-15.08170HCMHUTCHMED2.8081 of 5 stars$17.44+1.8%$19.00+8.9%-7.0%$3.04B$630.20M0.001,811Analyst ForecastMORMorphoSysN/A$18.96flatN/AN/A$2.86B$238.28M-5.45730RAREUltragenyx Pharmaceutical4.3494 of 5 stars$27.83+1.9%$83.64+200.6%-38.0%$2.63B$560.23M-4.721,294Upcoming EarningsARWRArrowhead Pharmaceuticals3.879 of 5 stars$18.98+3.7%$43.71+130.4%-44.7%$2.62B$545.21M-13.55400ALVOAlvotech2.8685 of 5 stars$8.68+3.1%$18.00+107.4%-22.4%$2.62B$585.60M23.451,032MIRMMirum Pharmaceuticals3.9526 of 5 stars$52.790.0%$65.50+24.1%+32.0%$2.61B$336.89M-32.79140CPRXCatalyst Pharmaceuticals4.9136 of 5 stars$21.37+0.9%$32.83+53.7%+22.8%$2.61B$491.73M13.6180News CoveragePositive News Related Companies and Tools Related Companies IMVT Alternatives CRNX Alternatives KYMR Alternatives HCM Alternatives MOR Alternatives RARE Alternatives ARWR Alternatives ALVO Alternatives MIRM Alternatives CPRX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SION) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredElon Just Fired the IRS Agents Targeting Your SavingsElon Musk just fired 6,700 IRS agents — and exposed a war on your retirement. While D.C. scrambles to regai...Priority Gold | SponsoredFREE GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...GoldCo Precious Metals | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredBitcoin Beats Gold — But This Coin Could Beat Them BothBitcoin just hit a record high—but it’s not the top crypto play right now. Crypto analyst Juan Villaverde, ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sionna Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sionna Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SION Stock Alerts